RETATRUTIDE 60MG (T)
$427.99
Third-Party Verified Test Report
This product has been independently analyzed for identity and purity.
For Research Use Only
Retatrutide
Lyophilized peptide • Not for human or veterinary use
Retatrutide is a triple-agonist research peptide that targets GLP-1, GIP, and
glucagon receptors. It is being studied for its potential to influence
energy expenditure, glucose regulation, and body composition
in metabolic research models. This multi-pathway approach allows for comprehensive study of incretin-related
metabolic and appetite signaling.
Key Research Points
- Triple agonist of GLP-1, GIP, and glucagon receptors
- Explored for effects on metabolic rate and energy balance
- Studied for appetite regulation and lipid metabolism research
- May provide insight into next-generation incretin-based mechanisms
Form
Lyophilized Powder
Appearance
White to off-white lyophilized powder
Storage
Refrigerate 2–8°C or store below 25°C dry
Category
GLP/GIP/Glucagon Research Compound
Aviso: For laboratory research use only. Not approved for human or veterinary use, ingestion, or medical applications.
Reconstitute using sterile technique under controlled laboratory conditions.
Reconstitute using sterile technique under controlled laboratory conditions.
